These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 5818008)
1. [Studies on the phase diagram of aminopyrine-barbital-water system and crystal data of the molecular compound of aminopyrine and barbital]. Kiryu S; Iguchi S Yakugaku Zasshi; 1969 May; 89(5):707-11. PubMed ID: 5818008 [No Abstract] [Full Text] [Related]
2. [Raman spectra and structure of molecular addition compound of aminopyrine and barbital in aqueous solution]. KASHIMA T; WATARI T; MIKUBO H Eisei Shikenjo Hokoku; 1961 Sep; 79():59-63. PubMed ID: 14454136 [No Abstract] [Full Text] [Related]
3. Enhancement effects of barbital on the teratogenicity of aminopyrine. Nomura T; Isa Y; Kurokawa N; Kanzaki T; Tanaka H; Tada E; Sakamoto Y Toxicology; 1984 Feb; 29(4):281-91. PubMed ID: 6701899 [TBL] [Abstract][Full Text] [Related]
4. Direct preparation of solid particulates of aminopyrine-barbital complex (pyrabital) from droplets by a spray-drying technique. Kawashima Y; Lin SY; Ueda M; Takenaka H; Ando Y J Pharm Sci; 1983 May; 72(5):514-8. PubMed ID: 6864497 [TBL] [Abstract][Full Text] [Related]
5. Characteristic biotransformation of aminopyrine in rat when administered with barbital. Matsuyama K; Kado K; Nishiuchi M; Goromaru T; Tsuzuki O; Noda A; Iguchi S J Pharmacobiodyn; 1981 Jan; 4(1):28-34. PubMed ID: 7277190 [TBL] [Abstract][Full Text] [Related]
6. Studies on the polymorphism of barbital. Grabowska I; Kaliszan R Pol J Pharmacol Pharm; 1976; 28(5):529-36. PubMed ID: 1012979 [TBL] [Abstract][Full Text] [Related]
7. [Teratogenicity of aminopyrine and its molecular compound with barbital]. Nomura T; Isa Y; Sakamoto Y Yakugaku Zasshi; 1981 May; 101(5):470-6. PubMed ID: 7288588 [No Abstract] [Full Text] [Related]
8. Crystal structure of a 1:1 aminopyrine-barbital complex. Kiryu S J Pharm Sci; 1971 May; 60(5):699-703. PubMed ID: 5125767 [No Abstract] [Full Text] [Related]
9. Crystal structure of a 1:1 aminopyrine-cyclobarbital complex. Kiryu S; Hirayama F; Iguchi S Chem Pharm Bull (Tokyo); 1974 Jul; 22(7):1588-92. PubMed ID: 4434581 [No Abstract] [Full Text] [Related]
10. [On the polymorphism of barbiturates in powders and tablets. Part 2: On the infrared spectroscopy and the X-ray diffractometry of barbital (author's transl)]. Hollenbach K; Mezösi J; Pintye-Hódi K; Kedvessy G Pharmazie; 1979 Apr; 34(4):240-2. PubMed ID: 482331 [TBL] [Abstract][Full Text] [Related]
11. [On the polymorphism of barbiturates in powders and tablets - Part 3: The effect of the pressing power on the modification of barbital (author's transl)]. Pintye-Hódi K; Hollenbach K Pharmazie; 1979 Dec; 34(12):807-8. PubMed ID: 545349 [TBL] [Abstract][Full Text] [Related]
12. [Enhancement effects of barbital and phenobarbital on aminopyrine-initiated teratogenesis in mice]. Isa Y; Nomura T Yakugaku Zasshi; 1981 May; 101(5):477-81. PubMed ID: 7288589 [No Abstract] [Full Text] [Related]
13. [On the polymorphism of barbiturates in powders and tablets. Part 1: Crystal optical studies on, and melting behaviour of barbital (author's transl)]. Hollenbach K; Pintye-Hódi K; Kedvessy G Pharmazie; 1979; 34(3):164-7. PubMed ID: 450956 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of 1:1 complex of barbital with 1-methylimidazole. Wang A; Craven BM J Pharm Sci; 1979 Mar; 68(3):361-3. PubMed ID: 423128 [TBL] [Abstract][Full Text] [Related]
15. [Effect of complex formation on interfacial transfer rate of drugs across two liquid phases (author's transl)]. Kiryu S; Tateyama T; Iguchi S Yakugaku Zasshi; 1982 Jan; 102(2):207-10. PubMed ID: 7108751 [No Abstract] [Full Text] [Related]
16. [Comparative action of barbital and of barbital associated with amibophenazone on respiratory function in the rabbit]. Carminati GM; Spina G Boll Chim Farm; 1965 May; 104(5):309-16. PubMed ID: 5826889 [No Abstract] [Full Text] [Related]
17. [Comparative action of barbital and of barbital associated with aminophenazone on basal metabolism and on mortality rate in the rat]. Carminati GM; Spina G Boll Chim Farm; 1965 May; 104(5):317-22. PubMed ID: 5826890 [No Abstract] [Full Text] [Related]
18. Effect of combination of pharmaceuticals on gastrointestinal absorption. 3. Combination of aminopyrine and barbital. Goto S; Tsuzuki O; Iguchi S Chem Pharm Bull (Tokyo); 1971 May; 19(5):944-53. PubMed ID: 5557931 [No Abstract] [Full Text] [Related]
19. Barbital-induced cross-tolerance to barbiturates by the intracisternal route of administration. Stolman S; Loh HH Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):309-16. PubMed ID: 1197916 [TBL] [Abstract][Full Text] [Related]
20. Relationship between enhancement of plasma level of aminopyrine by barbital and stomach emptying pattern. Goto S; Tsuzuki O; Iguchi S J Pharm Sci; 1972 Jun; 61(6):945-7. PubMed ID: 5046117 [No Abstract] [Full Text] [Related] [Next] [New Search]